参考文献/References:
[1] Hay ID,Bayer MF,Kaplan MM,et al. American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays The Committee on Nomenclature of the American Thyroid[J]. Clin Chem,1991,37(11):2002-2008.
[2] Stockigt JR. Guidelines for diagnosis and monitoring of thyroid disease:nonthyroidal illness[J]. Clin Chem,1996,42(1):188-192.
[3] Owen PJ,Lazarus JH. Subclinical hypothyroidism:the case for treatment[J]. Trends Endocrinol Metab,2003,14(16):257-261.
[4] Tunbridge WM,Vanderpump MP. Population screening for autoimmune thyroid disease[J].Endocrinol Metab Clin North Am,2000,29(2):239-253.
[5] 乔洁,陈名道.亚临床甲状腺疾病的诊断、治疗及病例分析[J]. 中华内分泌代谢杂志,2004,20(2):附录U001-U002.
[6] Surks MI,Ortiz E,Daniels GH,et al. Subclinical thyroid disease:scientific review and guidelines for diagnosis and management[J]. JAMA,2004,291(2):228-238.
[7] 滕卫平.开展亚临床甲状腺功能减退症的临床研究[J].中华内分泌代谢杂志,2004,20(2):93-95.
[8] Fatourechi V,Laukorani M,Schryver PG,et al. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mIU/L)[J]. Mayo Clin Proc,2003,78(5):554-560.
[9] Jorde R,Waterloo K,Storhaug H,et al. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment[J].J Clin Endocrinol Metab,2006,91(1):145-153.
[10] Altinova AE,Törüner FB,Aktuük M,et al. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism[J]. Clin Endocrinol(Oxf),2006,65(4):530-535.
[11] 阳俊琴.第一届全国老年人内分泌代谢系统疾病学术会议纪要[J].中华老年医学杂志,2003,22(7):440.
[12] Barbé F,Klein M,Chango A,et al. Homocysteine,folate,vitamin B12,and transcobalamins in pationts undergoing successive hypo-and hyperthyroid states[J].J Clin Endocrinol Metab,2001,86(4):1845-1846.
[13] Devaraj S,Xu DY,Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells:implications for the metabolic syndrome and atherothrombosis[J]. Circulation,2003,107(3):398-404.
[14] Cantürk Z,Cetinarslan B,Tarkun I,et al. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism[J]. Thyroid,2003,13(10):971-977.
[15] Kahaly GJ.Cardiovascular and atherogenic aspects of subclinical hypothyroidism[J]. Thyroid,2000,10(8):665-679.
[16] Rodondi N,Newman AB,Vittinghoff E,et al. Subclinical hypothyroidism and the risk of heart failure,other cardiovascular events,and death[J],Arch intern Med,2005,165(21):2460-2466.
[17] Díez JJ,Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years:an analysis of natural course and factors for the development of overt thyroid failure[J]. J Clin Endocrinol Metab,2004,89(10):4890-4897.
[18] 李新禾.亚临床甲亢108例临床分析[J].实用糖尿病杂志,2007,15(5):36-37.
[19] Biondi B,Palmieri EA,Klain M,et al. Subclinical hyperthyroidism:clinical features and treatment options[J]. Eur J Endocrinol,2005,152(1):1-9.
[21] Cappola AR,Fried LP,Arnold AM. Thyroid status,cardiovascular risk,and mortality in older adults[J]. JAMA,2006,295(9):1033-1041.
[22] Cavallo-Perin P,Bruno A,Boine L,et al. Insulin resistance in Graves’ disease:a quantitative in-vivo evaluation[J]. Eur J Clin Invest,1988,18(16):607-613.
相似文献/References:
[1]贾强,孟召伟,谭建.异位甲状腺发病机理、诊断与治疗的研究进展[J].国际放射医学核医学杂志,2016,40(4):297.[doi:10.3760/cma.j.issn.1673-4114.2016.04.012]
Jia Qiang,Meng Zhaowei,Tan Jian.Progress of pathogenisis, diagnosis and treatment of ectopic thyroid[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):297.[doi:10.3760/cma.j.issn.1673-4114.2016.04.012]
[2]惠金子,赵德善.Tg、TgAb及TSH在分化型甲状腺癌术前的预测分析[J].国际放射医学核医学杂志,2015,39(2):110.[doi:10.3760/cma.j.issn.1673-4114.2015.02.002]
Hui Jinzi,Zhao Deshan.The prediction of risk of differentiated thyroid carcinoma with preoperative serum thyroid stimulating hormone, thyrogiobulin and antithyroglobulin antibody[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):110.[doi:10.3760/cma.j.issn.1673-4114.2015.02.002]
[3]陈雪梅,周树云,范源,等.表没食子儿茶素没食子酸酯对131I辐射损伤所致甲减大鼠模型抗氧化体系的保护作用[J].国际放射医学核医学杂志,2015,39(4):311.[doi:10.3760/cma.j.issn.1673-4114.2015.04.009]
Chen Xuemei,Zhou Shuyun,Fan Yuan,et al.Protection of antioxidant system of EGCG on the thyroid in rat model from 131I radiation damage[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):311.[doi:10.3760/cma.j.issn.1673-4114.2015.04.009]
[4]李敬彦,蒋宁一.分化型甲状腺癌术后131I清甲治疗方法的相关问题[J].国际放射医学核医学杂志,2014,38(1):42.[doi:10.3760/cma.j.issn 1673-4114.2014.01.009]
Li Jingyan,Jiang Ningyi.Issues related to radioactive iodine ablation in patients with differentiated thyroid carcinoma under-going thyroid surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):42.[doi:10.3760/cma.j.issn 1673-4114.2014.01.009]
[5]程维维,王辉.促甲状腺激素受体与甲状腺癌关系的研究进展[J].国际放射医学核医学杂志,2012,36(2):69.[doi:10.3760/cma.j.issn.1673-4114.2012.02.002]
CHENG Wei-wei,WANG Hui.Progress in the relationship of thyroid-stimulating hormone receptor and thyroid carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(6):69.[doi:10.3760/cma.j.issn.1673-4114.2012.02.002]
[6]黄丽娟,陈宁,叶静,等.反义肽核酸对促甲状腺激素受体mRNA表达的影响[J].国际放射医学核医学杂志,2012,36(5):310.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.011]
HUANG Li-juan,CHEN Ning,YE Jing,et al.The effects of antisense peptide nucleic acid on the expression of thyroid stimulating hormone receptor mRNA[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(6):310.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.011]
[7]钟兴祥,郑吉祥,蓝冠章,等.Graves甲亢131I治疗前后血清TRAb动态变化及临床价值[J].国际放射医学核医学杂志,2011,35(2):110.[doi:10.3760/cma.j.issn.1673-4114.2011.02.011]
ZHONG Xing-xiang,ZHENG Ji-xiang,LAN Guan-zhang,et al.Changes of serum TRAb after 131I radiotherapy in patients of Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):110.[doi:10.3760/cma.j.issn.1673-4114.2011.02.011]
[8]王金萍,吴秋莲,徐浩.甲状腺功能与血清饥饿素和瘦素水平的相关陛研究[J].国际放射医学核医学杂志,2008,32(4):221.
WANG Jin-Lian,WU Qiu-lion,XU Hao.Association of thyroid function with human serum ghrelin and leptin levels[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(6):221.
[9]李诗运,谭本旭,戴儒奇,等.优甲乐和稳定性碘干预131I致大鼠甲状腺功能减低的研究[J].国际放射医学核医学杂志,2007,31(6):325.
LI Shi-yun,TAN Ben-xu,DAI Ru-qi,et al.Interventions of euthyrox and stable iodine in hypothyroid occurrence of rats treated with 131I[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(6):325.
[10]孟召伟,谭建.重组人促甲状腺激素和促再分化药物在分化型甲状腺癌中的应用[J].国际放射医学核医学杂志,2006,30(6):338.
MENG Zhao-wei,TAN Jian.Application of recombinant human thyrotropin and redifferentiation drugs in differentiated thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(6):338.
[11]孟召伟,谭建.美国甲状腺协会和临床内分泌医师协会2012年甲减诊治指南介绍[J].国际放射医学核医学杂志,2013,37(2):124.[doi:10.3760/cma.j.issn.1673-4114.2013.02.016]
MENG Zhao-wei,TAN Jian.Reading and analysis on management guidelines for hypothyroidism published in 2012 by American Thyroid Association and American Association of Clinical Endocrinologists[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):124.[doi:10.3760/cma.j.issn.1673-4114.2013.02.016]